Nephrocare IPO Subscription Status: IPO Receives 0.97 Times Subscription Applications by Noon of Day 3
By Shishta Dutta | Updated at: Dec 12, 2025 05:26 PM IST
December 12, 2025: Nephrocare Health Services IPO received 0.97 times subscription status applications by noon of Day 3. The company is a dialysis services provider. The company, based in Hyderabad, has set the price band between ₹438-460 per share. The Nephrocare IPO is a combination of the fresh issue of shares worth ₹353.4 crore and an Offer For Sale (OFS) of 1.12 crore shares worth ₹517.6 crore, at the upper end of the price band.
Details of Nephrocare IPO Subscription Status
The IPO got a subscription status of 0.97 times by 12:59 pm IST on the third day. The retail segment was subscribed 0.88 times and the NII segment was logged 0.30 times, while the QIBs (Qualified Institutional Buyers) segment got 2.07 times bids. Also, the employee segment was subscribed 1.92 times.
The company has got bids for 62.83 lakh shares against an offer of 1.32 crore shares.
Nephrocare IPO Subscription status Day 2 retail category recap: the issue witnessed 0.37 times subscription status by EOD. The IPO recorded 0.29 times subscription status by QIB (Ex Anchor) buyers, 0.23 times subscription in the NII category.
Nephrocare IPO Details
Nephrocare Health Services IPO is a book-building issue of ₹871.05 crore, which includes a fresh issue of ₹353.40 crore and an offer for sale of ₹517.64 crore. The price band has been fixed between ₹438 and ₹460 per share, and the lot size is 32 shares. Thus, a retail investor needs to invest a minimum of ₹14,016 to participate in the Nephrocare Health Services IPO.
The book-running lead managers are ICICI Securities Ltd., Ambit Private Limited, IIFL Capital Services Limited (Formerly known as IIFL Securities Limited) and Nomura Financial Advisory and Securities (India) Private Limited. Kfin Technologies Ltd. is the registrar for the issue.
NephroPlus (Nephrocare Health Services Ltd.) is the biggest provider of dialysis services in India and Asia. The public subscription status window for Nephrocare Health Services IPO will be ending today, December 12, 2025.
The decision on the share allocation for the Nephrocare Health Services IPO will be made on December 15, 2025. The shares will be listed on both the NSE and the BSE. The tentative date for the listing is December 17, 2025.
Source: https://www.bseindia.com/markets/publicIssues/DisplayIPO.aspx?id=4350&type=IPO&idtype=1&status=L&IPONo=7492&startdt=10/Dec/2025
Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations
